{"id":531533,"date":"2021-08-25T20:03:14","date_gmt":"2021-08-26T00:03:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/"},"modified":"2021-08-25T20:03:14","modified_gmt":"2021-08-26T00:03:14","slug":"anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/","title":{"rendered":"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN DIEGO<\/span>, Aug. 25, 2021<\/span> \/PRNewswire\/ — Robbins Geller Rudman<\/span> & Dowd LLP<\/a><\/b> announces that purchasers of Annovis Bio, Inc. (NYSE: ANVS) securities between May 21, 2021<\/span> and July 28, 2021<\/span>, inclusive (the “Class Period”), have until October 18, 2021<\/span> to seek appointment as lead plaintiff in the Annovis Bio<\/i> class action lawsuit.\u00a0 The Annovis Bio <\/i>class action lawsuit (Zhou v. Annovis Bio, Inc.<\/i>, No. 21-cv-03668) charges Annovis Bio and certain of its top executives with violations of the Securities Exchange Act of 1934.\u00a0 The Annovis Bio <\/i>class action lawsuit was commenced on August 17, 2021<\/span> in the Eastern District of Pennsylvania<\/span> and is assigned to Judge Chad F. Kenney<\/span>.<\/p>\n

\n If you wish to serve as lead plaintiff of the Annovis Bio <\/i>class action lawsuit, please provide your information by clicking here<\/a>.\u00a0 You can also contact attorney J.C. Sanchez<\/a> of Robbins Geller by calling 800\/449-4900 or via e-mail at jsanchez@rgrdlaw.com<\/a>.\u00a0 Lead plaintiff motions for the Annovis Bio<\/i> class action lawsuit must be filed with the court no later than October 18, 2021<\/span>.<\/b>\n <\/p>\n

\n CASE ALLEGATIONS<\/b>: Annovis Bio is a clinical stage pharmaceutical company and its lead compound is ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration.<\/p>\n

The Annovis Bio <\/i>class action lawsuit alleges that, throughout the Class Period, defendants made false and misleading statements and failed to disclose that: (i) Annovis Bio’s ANVS401 did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (ii) as a result, defendants’ positive statements about Annovis Bio’s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n

On July 28, 2021<\/span>, Annovis Bio reported interim clinical data from its Phase 2a trial.\u00a0 Among other things, Annovis Bio reported that Alzheimer’s disease patients 25 days after treatment failed to show statistically significant improvement compared to the placebo.\u00a0 Annovis Bio also reported that, although patients showed cognitive improvements in certain areas, the results were not statistically significant.\u00a0 On this news, Annovis Bio’s share price fell approximately 60%, damaging investors.<\/p>\n

\n THE LEAD PLAINTIFF PROCESS<\/b>: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased Annovis Bio securities during the Class Period to seek appointment as lead plaintiff in the Annovis Bio <\/i>class action lawsuit.\u00a0 A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.\u00a0 A lead plaintiff acts on behalf of all other class members in directing the Annovis Bio<\/i> class action lawsuit.\u00a0 The lead plaintiff can select a law firm of its choice to litigate the Annovis Bio<\/i> class action lawsuit.\u00a0 An investor’s ability to share in any potential future recovery of the Annovis Bio<\/i> action lawsuit is not dependent upon serving as lead plaintiff.\u00a0<\/p>\n

\n ABOUT ROBBINS GELLER RUDMAN & DOWD LLP<\/b>: With 200 lawyers in 9 offices nationwide, Robbins Geller Rudman & Dowd LLP is the largest U.S. law firm representing investors in securities class actions.\u00a0 Robbins Geller attorneys have obtained many of the largest shareholder recoveries in history, including the largest securities class action recovery ever \u2013 $7.2 billion<\/span> \u2013 in In re Enron Corp. Sec. Litig<\/i>.\u00a0 The 2020 ISS Securities Class Action Services Top 50 Report ranked Robbins Geller first for recovering $1.6 billion<\/span> for investors last year, more than double the amount recovered by any other securities plaintiffs’ firm.\u00a0 Please visit http:\/\/www.rgrdlaw.com<\/a> for more information.\u00a0<\/p>\n

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.<\/p>\n

Contact:<\/p>\n

Robbins Geller Rudman<\/span> & Dowd LLP
655 W. Broadway, San Diego<\/span>, CA\u00a0 92101
J.C. Sanchez, 800-449-4900
jsanchez@rgrdlaw.com<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit-301361935.html<\/a><\/p>\n

SOURCE Robbins Geller Rudman & Dowd LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN DIEGO, Aug. 25, 2021 \/PRNewswire\/ — Robbins Geller Rudman & Dowd LLP announces that purchasers of Annovis Bio, Inc. (NYSE: ANVS) securities between May 21, 2021 and July 28, 2021, inclusive (the “Class Period”), have until October 18, 2021 to seek appointment as lead plaintiff in the Annovis Bio class action lawsuit.\u00a0 The Annovis Bio class action lawsuit (Zhou v. Annovis Bio, Inc., No. 21-cv-03668) charges Annovis Bio and certain of its top executives with violations of the Securities Exchange Act of 1934.\u00a0 The Annovis Bio class action lawsuit was commenced on August 17, 2021 in the Eastern District of Pennsylvania and is assigned to Judge Chad F. Kenney. If you wish to serve as lead plaintiff … <\/p>\n

Continue reading “ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-531533","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN DIEGO, Aug. 25, 2021 \/PRNewswire\/ — Robbins Geller Rudman & Dowd LLP announces that purchasers of Annovis Bio, Inc. (NYSE: ANVS) securities between May 21, 2021 and July 28, 2021, inclusive (the “Class Period”), have until October 18, 2021 to seek appointment as lead plaintiff in the Annovis Bio class action lawsuit.\u00a0 The Annovis Bio class action lawsuit (Zhou v. Annovis Bio, Inc., No. 21-cv-03668) charges Annovis Bio and certain of its top executives with violations of the Securities Exchange Act of 1934.\u00a0 The Annovis Bio class action lawsuit was commenced on August 17, 2021 in the Eastern District of Pennsylvania and is assigned to Judge Chad F. Kenney. If you wish to serve as lead plaintiff … Continue reading "ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-26T00:03:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA85036&sd=2021-08-25\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit\",\"datePublished\":\"2021-08-26T00:03:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/\"},\"wordCount\":639,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA85036&sd=2021-08-25\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/\",\"name\":\"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA85036&sd=2021-08-25\",\"datePublished\":\"2021-08-26T00:03:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA85036&sd=2021-08-25\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA85036&sd=2021-08-25\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/","og_locale":"en_US","og_type":"article","og_title":"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit - Market Newsdesk","og_description":"PR Newswire SAN DIEGO, Aug. 25, 2021 \/PRNewswire\/ — Robbins Geller Rudman & Dowd LLP announces that purchasers of Annovis Bio, Inc. (NYSE: ANVS) securities between May 21, 2021 and July 28, 2021, inclusive (the “Class Period”), have until October 18, 2021 to seek appointment as lead plaintiff in the Annovis Bio class action lawsuit.\u00a0 The Annovis Bio class action lawsuit (Zhou v. Annovis Bio, Inc., No. 21-cv-03668) charges Annovis Bio and certain of its top executives with violations of the Securities Exchange Act of 1934.\u00a0 The Annovis Bio class action lawsuit was commenced on August 17, 2021 in the Eastern District of Pennsylvania and is assigned to Judge Chad F. Kenney. If you wish to serve as lead plaintiff … Continue reading \"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-26T00:03:14+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA85036&sd=2021-08-25","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit","datePublished":"2021-08-26T00:03:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/"},"wordCount":639,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA85036&sd=2021-08-25","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/","name":"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA85036&sd=2021-08-25","datePublished":"2021-08-26T00:03:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA85036&sd=2021-08-25","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA85036&sd=2021-08-25"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anvs-notice-investors-with-substantial-losses-have-opportunity-to-lead-the-annovis-bio-inc-class-action-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ANVS NOTICE: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=531533"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531533\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=531533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=531533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=531533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}